Preferred Pharmaceuticals, Inc. 2023-04-12 Health serious FDA
Health · FDA · Recall #FDA-D-0512-2023
Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC… Recall
Issued April 12, 2023 · Preferred Pharmaceuticals, Inc.
In April 2023, Preferred Pharmaceuticals, Inc. recalled the Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
What you should do
- 1 Stop using Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Preferred Pharmaceuticals, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Preferred Pharmaceuticals, Inc.
- Category
- Health
- Recall date
- April 12, 2023
- Units affected
- Not reported
- Sold at
- USA Nationwide
- Recall number
- FDA-D-0512-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Preferred Pharmaceuticals, Inc. has 16 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.